Bisphosphonate use is associated with atypical periprosthetic femoral fractures in hip and knee arthroplasty patients, according to a study in Journal of Bone and Mineral Research.
Zavation is an employee-owned spine surgery company.
Stryker has made big moves in 2018, especially over the past three months, to grow the company across several business lines.
The global spinal implants market is forecasted to grow at a 7 percent compound annual growth rate to exceed $19.5 billion by 2024, according to a Market Research Engine report.
Here are 12 key notes from orthopedic and spine device companies in the past week.
Camille Farhat, president and CEO of RTI Surgical, discusses the key technology trends in spine today and where his company is headed in the future.
Medacta International appointed Francesco Siccardi as CEO, effective Nov. 1.
About a month after it's billion-dollar acquisition of K2M, Stryker continues to make smaller acquisitions to complement its product portfolio.
Interventional pain management physician Claudio Vincenty, MD, has focused his career around back pain management. He has a special interest in spinal cord stimulation and advanced implant therapies.
The FDA granted Zimmer Biomet's request to extend its Mobi-C Cervical Disc labeling to include seven-year clinical results.